InvestorsHub Logo
icon url

misiu143

03/29/21 12:32 PM

#155402 RE: Bill_ENG #155397

Yes , thank you I read after I listened to CC ,
It will be interesting what FDA will do now..
icon url

Emergcy

03/29/21 1:02 PM

#155415 RE: Bill_ENG #155397

Very good paper. Thank you. Make aways:
1) known and applied for 35 years
2) leads faster to useful results
3) USA and Europe open these trials
4) planning sophisticated
5) evaluation a real science and tricky
6) need good will from regulators

I am sure this is a NO GO for small biotecs like cydy. That's the reason they were talking constantly with FAUCI clan. The evaluation is in no way done in just days or few weeks. This is a difficult task if FDA would be objective which I believe they are not. If they get any EUA within 2 months then we have the confirmation that all is a foolish and corrupted game.
icon url

3X Charm

03/29/21 5:26 PM

#155442 RE: Bill_ENG #155397

“Apparently it is an option”

Apparently not for CEO’s out of their depth in the pharma industry and a third rate CRO, which offers cheap, rather than effective service.